N. S. Yubitskaya, A. V. Yurenko, N. G. Kos`yanenko, E. Mineeva
{"title":"Сombined rehabilitation after COVID-19 coronavirus infection","authors":"N. S. Yubitskaya, A. V. Yurenko, N. G. Kos`yanenko, E. Mineeva","doi":"10.34215/1609-1175-2023-4-32-36","DOIUrl":null,"url":null,"abstract":"Aim. To study the efficacy of personalized combined rehabilitation of PCS patients in the setting of a day hospital.Materials and methods. The study involved 68 patients with PCS (49 women and 19 men) aged from 36 to 76 years. Bronchial asthma (BA) was detected in 26 patients, chronic obstructive pulmonary disease (COPD)– in 9 patients, and stage II hypertension– in 12 patients. Depending on severity of PCS, the treatment program included drug therapy and physiotherapeutic treatment. The rehabilitation course lasted for 14 days. The efficacy of medical rehabilitation was assessed by the dynamics of clinical and functional indicators.Results. After the rehabilitation course, asthenic syndrome decreased in all patients. The majority of patients reported improvement in dyspnea according to the mMRC scale. In COPD patients, the CAT test score decreased by 26%. After rehabilitation, the asthma patients showed a decrease in the ACQ test score by 45%, with the peakflowmetry indicators having improved. Improvements in spirometry and peripheral oxygen saturation of capillary blood were recorded.Conclusion. Personalized medical rehabilitation of patients after coronavirus infection can reduce the severity of PCS signs. The rehabilitation methods used contributed to the restoration of external respiratory function, stabilization of the patients’ emotional state, reduction of shortness of breath, hypoxemia, and other impaired functions in patients after COVID-19.","PeriodicalId":19705,"journal":{"name":"Pacific Medical Journal","volume":"28 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pacific Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34215/1609-1175-2023-4-32-36","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aim. To study the efficacy of personalized combined rehabilitation of PCS patients in the setting of a day hospital.Materials and methods. The study involved 68 patients with PCS (49 women and 19 men) aged from 36 to 76 years. Bronchial asthma (BA) was detected in 26 patients, chronic obstructive pulmonary disease (COPD)– in 9 patients, and stage II hypertension– in 12 patients. Depending on severity of PCS, the treatment program included drug therapy and physiotherapeutic treatment. The rehabilitation course lasted for 14 days. The efficacy of medical rehabilitation was assessed by the dynamics of clinical and functional indicators.Results. After the rehabilitation course, asthenic syndrome decreased in all patients. The majority of patients reported improvement in dyspnea according to the mMRC scale. In COPD patients, the CAT test score decreased by 26%. After rehabilitation, the asthma patients showed a decrease in the ACQ test score by 45%, with the peakflowmetry indicators having improved. Improvements in spirometry and peripheral oxygen saturation of capillary blood were recorded.Conclusion. Personalized medical rehabilitation of patients after coronavirus infection can reduce the severity of PCS signs. The rehabilitation methods used contributed to the restoration of external respiratory function, stabilization of the patients’ emotional state, reduction of shortness of breath, hypoxemia, and other impaired functions in patients after COVID-19.